Drugs / HAC1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01177202 | Sep 2010 → May 2011 | swine influenza | Fraunhofer, Center for Molecular Biotechnology | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HAC1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01177202 ↗ |
| Known as | HAC1 Vaccine | “Biological: HAC1 Vaccine” NCT01177202 ↗ |
| Modality | Vaccine | “A subunit influenza vaccine, HAC1, based on recombinant hemagglutinin” PMID 24126211 ↗ Oct 2013 |